India Microbiology Testing Market to Grow with a CAGR of 10.26% through 2030
Increasing concerns about foodborne
illnesses and increase in the growth of the food processing and manufacturing
industry is expected to drive the India Microbiology Testing Market growth in
the forecast period, 2026-2030.
According to TechSci Research report, “India Microbiology
Testing Market – By Region, Competition, Forecast
& Opportunities, 2030F”, India Microbiology Testing Market was
valued at USD 178.13 million in 2024 and is anticipated to project impressive
growth in the forecast period with a CAGR of 10.26% through 2030.
The growing awareness among individuals about
Microbiology Testing has created favorable market dynamics for the India
Microbiology Testing market. Multiple factors contribute to the rising demand
for diverse Microbiology Testing products.
The India Microbiology Testing Market is closely
associated with the nation’s increasing disease burden. It plays a pivotal role
in disease control, enabling early diagnosis, antibiotic resistance monitoring,
and outbreak management. With continuous innovations and investments, the
market is expected to grow significantly, aiding India’s response to mounting
health issues. India’s food safety regulations are robust and closely monitored
by FSSAI and state food bodies. Microbiology testing is essential in ensuring
adherence to these standards, from identifying pathogens to maintaining product
quality. As the food industry modernizes, testing will remain vital in
protecting public health and supporting a safe food supply chain, thus
advancing market expansion.
In September 2023, BD India introduced the BD
FACSVerse™ Flow Cytometer, an accessible and user-friendly tool for clinical
and research settings. It supports the diagnosis and monitoring of blood
cancers, infectious, and autoimmune diseases. India’s pharmaceutical sector has
become a global leader due to economical production and a focus on R\&D. It
manufactures generics, APIs, and biosimilars for both local and global markets.
With the rapid spread of infectious diseases, microbiology testing is vital for
quick diagnosis and response. It aids in antibiotic stewardship by guiding
precise antibiotic use. In both food and pharmaceutical sectors, microbiology
testing ensures product safety and quality, preventing contamination and
ensuring regulatory compliance.
Browse over XX market data Figures
spread through XX Pages and an in-depth TOC on "India Microbiology Testing
Market”
India Microbiology Testing Market is segmented
into type, product, indication, application, end-user, regional distribution,
and company.
Based on end user, the hospitals and diagnostic centers
segment was projected to experience rapid growth during the forecast period.
Hospitals and diagnostic centers are at the forefront of healthcare delivery in
India. Timely and accurate diagnosis of infectious diseases is fundamental to
patient care, treatment decisions, and disease management. Microbiology testing
is a cornerstone of clinical diagnostics, enabling healthcare providers to
identify pathogens responsible for various infectious diseases. From
respiratory infections to urinary tract infections, sepsis, and
gastrointestinal illnesses, microbiology testing plays a pivotal role in
diagnosing these conditions. The availability of rapid microbiology testing
methods, including molecular diagnostics, has revolutionized disease diagnosis
in hospitals and diagnostic centers. These tests provide quick results,
enabling healthcare providers to initiate appropriate treatment promptly.
Hospitals and diagnostic centers are crucial in
managing disease outbreaks and conducting epidemiological surveillance. These
institutions play a vital role in monitoring and controlling the spread of
infectious diseases, especially in densely populated areas. During outbreaks,
such as the COVID-19 pandemic, hospitals and diagnostic centers become hubs for
testing, contact tracing, and patient care. Microbiology testing, including
PCR-based testing for viruses, is central to identifying and isolating infected
individuals, thereby curbing the spread of contagious diseases. Government
healthcare agencies collaborate with hospitals and diagnostic centers to
establish testing and treatment facilities during public health emergencies.
The demand for microbiology testing in these settings surges during such times.
These factors collectively contribute to the growth of this segment.
Based on region, the South India market is poised to
be the fastest-growing market, offering lucrative growth opportunities for
Microbiology Testing Market players during the forecast period. Factors such as
South Indian states have made substantial investments in healthcare
infrastructure, including hospitals, diagnostic centers, and research
institutions. This expansion leads to increased demand for microbiology testing
services. South India has a growing pharmaceutical and biotechnology sector,
with companies engaged in research, development, and manufacturing. This
sector's growth drives the need for microbiology testing for quality control
and research purposes. The region is home to renowned educational and research
institutions, fostering collaborations in microbiology research. This
contributes to the demand for advanced microbiology testing methodologies.
South India attracts a significant number of medical tourists due to its
world-class healthcare facilities. These facilities require state-of-the-art
microbiology testing services, further boosting the market.
Major companies operating in
India Microbiology Testing Market are:
·
Cepheid India Private Limited
·
BD India Private Limited
·
BIO-RAD LABORATORIES (INDIA) PRIVATE
LIMITED.
·
Dr. Reddy's Laboratories Limited
·
Biocon Limited
·
Abbott India Limited
·
Beckman Coulter India Private Limited.
·
Agilent Technologies India Private
Limited.
·
Neogen Chemicals Limited.
·
Thermo Fisher Scientific India Private
Limited
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The India microbiology testing market is witnessing
strong growth driven by the need to detect and control microbial contamination
and rising awareness of infectious diseases. Expanding research in
biotechnology, pharmaceuticals, and biopharmaceuticals has intensified the
demand for microbiology testing to ensure product safety and efficacy.
Increasing consumer focus on preventive healthcare has boosted production of
health-related products. To meet evolving needs, manufacturers are adopting
advanced technologies, improving efficiency and product quality. Continuous
innovation and growing consumer trust are expected to further propel the
microbiology testing and supplements market in India, supporting public health
and regulatory compliance across sectors in the coming years” said Mr. Karan
Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“India Microbiology Testing Market By Type (Bacterial, Viral, Fungal), By Product (Instruments, Reagents), By Indication (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infection, Periodontal Diseases, Others), By Application (Pharmaceutical, Food Testing, Clinical, Energy, Chemical and Material Manufacturing, Environmental), By End-User (Hospitals and Diagnostic Centers, Custom Lab Service Providers, Academic, and Research Institutes), By Region, Competition, Forecast, Opportunities, 2020-2030F”,
has evaluated the future growth potential of India Microbiology Testing Market
and provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in India Microbiology Testing Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com